A gene-expression signature as a predictor of survival in breast cancer
- PMID: 12490681
- DOI: 10.1056/NEJMoa021967
A gene-expression signature as a predictor of survival in breast cancer
Abstract
Background: A more accurate means of prognostication in breast cancer will improve the selection of patients for adjuvant systemic therapy VSports手机版. .
Methods: Using microarray analysis to evaluate our previously established 70-gene prognosis profile, we classified a series of 295 consecutive patients with primary breast carcinomas as having a gene-expression signature associated with either a poor prognosis or a good prognosis. All patients had stage I or II breast cancer and were younger than 53 years old; 151 had lymph-node-negative disease, and 144 had lymph-node-positive disease V体育安卓版. We evaluated the predictive power of the prognosis profile using univariable and multivariable statistical analyses. .
Results: Among the 295 patients, 180 had a poor-prognosis signature and 115 had a good-prognosis signature, and the mean (+/-SE) overall 10-year survival rates were 54. 6+/-4. 4 percent and 94. 5+/-2. 6 percent, respectively. At 10 years, the probability of remaining free of distant metastases was 50. 6+/-4 V体育ios版. 5 percent in the group with a poor-prognosis signature and 85. 2+/-4. 3 percent in the group with a good-prognosis signature. The estimated hazard ratio for distant metastases in the group with a poor-prognosis signature, as compared with the group with the good-prognosis signature, was 5. 1 (95 percent confidence interval, 2. 9 to 9. 0; P<0. 001). This ratio remained significant when the groups were analyzed according to lymph-node status. Multivariable Cox regression analysis showed that the prognosis profile was a strong independent factor in predicting disease outcome. .
Conclusions: The gene-expression profile we studied is a more powerful predictor of the outcome of disease in young patients with breast cancer than standard systems based on clinical and histologic criteria. VSports最新版本.
Copyright 2002 Massachusetts Medical Society
Comment in
-
VSports app下载 - Predictive molecular pathology.N Engl J Med. 2002 Dec 19;347(25):1995-6. doi: 10.1056/NEJMp020155. N Engl J Med. 2002. PMID: 12490679 No abstract available.
-
Molecular signatures of breast cancer--predicting the future.N Engl J Med. 2002 Dec 19;347(25):2067-8. doi: 10.1056/NEJMe020152. N Engl J Med. 2002. PMID: 12490689 No abstract available.
-
Gene-expression signatures in breast cancer.N Engl J Med. 2003 Apr 24;348(17):1715-7; author reply 1715-7. doi: 10.1056/NEJM200304243481716. N Engl J Med. 2003. PMID: 12711750 No abstract available.
-
VSports在线直播 - Gene-expression signatures in breast cancer.N Engl J Med. 2003 Apr 24;348(17):1715-7; author reply 1715-7. N Engl J Med. 2003. PMID: 12712995 No abstract available.
-
Gene-expression signatures in breast cancer.N Engl J Med. 2003 Apr 24;348(17):1715-7; author reply 1715-7. N Engl J Med. 2003. PMID: 12712997 No abstract available.
-
V体育官网入口 - Gene-expression signatures in breast cancer.N Engl J Med. 2003 Apr 24;348(17):1715-7; author reply 1715-7. N Engl J Med. 2003. PMID: 12712998 No abstract available.
-
"V体育平台登录" A gene expression profile independently predicted disease outcome in young women with breast cancer.ACP J Club. 2003 May-Jun;138(3):82. ACP J Club. 2003. PMID: 12725637 No abstract available.
Publication types
MeSH terms (V体育平台登录)
- "V体育平台登录" Actions
- V体育安卓版 - Actions
- VSports注册入口 - Actions
- "VSports app下载" Actions
LinkOut - more resources
Full Text Sources (V体育官网入口)
Other Literature Sources
"V体育安卓版" Medical
Molecular Biology Databases